VMD
Income statement / Annual
Last year (2023), Viemed Healthcare, Inc.'s total revenue was $183.01 M,
an increase of 31.82% from the previous year.
In 2023, Viemed Healthcare, Inc.'s net income was $10.24 M.
See Viemed Healthcare, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$183.01 M
|
$138.83 M
|
$117.06 M
|
$131.31 M
|
$80.26 M
|
$65.27 M
|
$46.93 M
|
$31.36 M
|
$34.60 M
|
$23.29 M
|
| Cost of Revenue |
$70.23 M |
$54.15 M |
$43.65 M |
$51.20 M |
$24.25 M |
$16.69 M |
$12.31 M |
$12.50 M |
$7.82 M |
$3.86 M |
| Gross Profit |
$112.78 M |
$84.68 M |
$73.41 M |
$80.11 M |
$56.01 M |
$48.58 M |
$34.62 M |
$18.86 M |
$26.78 M |
$19.43 M |
| Gross Profit Ratio |
0.62 |
0.61 |
0.63 |
0.61 |
0.7 |
0.74 |
0.74 |
0.6 |
0.77 |
0.83 |
| Research and Development
Expenses |
$2.78 M
|
$2.70 M
|
$2.11 M
|
$1.08 M
|
$848,000.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative
Expenses |
$93.73 M
|
$73.36 M
|
$60.04 M
|
$57.71 M
|
$45.27 M
|
$30.68 M
|
$20.25 M
|
$13.77 M
|
$0.00
|
$0.00
|
| Selling & Marketing
Expenses |
-$538,000.00
|
-$5.20 M
|
$0.00
|
$0.00
|
$0.00
|
$268,000.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$93.20 M
|
$73.36 M
|
$60.04 M
|
$57.71 M
|
$45.27 M
|
$30.95 M
|
$20.25 M
|
$13.77 M
|
$16.74 M
|
$9.56 M
|
| Other Expenses |
$2.48 M |
$23,000.00 |
-$771,000.00 |
-$3.14 M |
$671,000.00 |
-$71,000.00 |
$402,000.00 |
$332,000.00 |
$0.00 |
$0.00 |
| Operating Expenses |
$98.45 M |
$76.08 M |
$61.38 M |
$55.66 M |
$46.79 M |
$31.54 M |
$20.65 M |
$14.10 M |
$16.74 M |
$9.93 M |
| Cost And Expenses |
$168.68 M |
$130.23 M |
$105.03 M |
$106.86 M |
$71.04 M |
$48.23 M |
$32.96 M |
$26.60 M |
$24.56 M |
$13.79 M |
| Interest Income |
$0.00 |
$197,000.00 |
$318,000.00 |
$509,000.00 |
$314,000.00 |
$0.00 |
$0.00 |
$0.00 |
$87,000.00 |
$48,000.00 |
| Interest Expense |
$424,000.00 |
$197,000.00 |
$318,000.00 |
$509,000.00 |
$314,000.00 |
$181,000.00 |
$272,000.00 |
$323,000.00 |
$0.00 |
$0.00 |
| Depreciation &
Amortization |
$21.86 M
|
$15.63 M
|
$11.31 M
|
$9.58 M
|
$6.40 M
|
$3.78 M
|
$2.54 M
|
$1.42 M
|
$955,088.00
|
$385,000.00
|
| EBITDA |
$36.68 M
|
$24.03 M
|
$21.84 M
|
$30.54 M
|
$15.62 M
|
$13.89 M
|
$11.37 M
|
$1.81 M
|
$11.94 M
|
$9.87 M
|
| EBITDA Ratio |
0.2 |
0.18 |
0.2 |
0.26 |
0.19 |
0.32 |
0.35 |
0.2 |
0.32 |
0.42 |
| Operating Income Ratio
|
0.08
|
0.06
|
0.1
|
0.2
|
0.11
|
0.26
|
0.19
|
0.01
|
0.29
|
0.41
|
| Total Other
Income/Expenses Net |
$61,000.00
|
$738,000.00
|
$923,000.00
|
-$418,000.00
|
-$61,000.00
|
-$386,000.00
|
-$633,000.00
|
-$274,000.00
|
-$87,000.00
|
-$34,000.00
|
| Income Before Tax |
$14.39 M |
$8.99 M |
$12.50 M |
$26.36 M |
$8.80 M |
$10.34 M |
$8.19 M |
$109,000.00 |
$9.96 M |
$9.45 M |
| Income Before Tax Ratio
|
0.08
|
0.06
|
0.11
|
0.2
|
0.11
|
0.16
|
0.17
|
0
|
0.29
|
0.41
|
| Income Tax Expense |
$4.15 M |
$2.77 M |
$3.38 M |
-$5.17 M |
$271,000.00 |
$162,000.00 |
$15,000.00 |
-$1.12 M |
$1.03 M |
$0.00 |
| Net Income |
$10.24 M |
$6.22 M |
$9.13 M |
$31.53 M |
$8.53 M |
$10.18 M |
$8.18 M |
$1.23 M |
$8.93 M |
$9.45 M |
| Net Income Ratio |
0.06 |
0.04 |
0.08 |
0.24 |
0.11 |
0.16 |
0.17 |
0.04 |
0.26 |
0.41 |
| EPS |
0.27 |
0.15 |
0.23 |
0.86 |
0.23 |
0.27 |
0.22 |
0.0324 |
0.24 |
1.58 |
| EPS Diluted |
0.25 |
0.15 |
0.22 |
0.82 |
0.22 |
0.26 |
0.22 |
0.0324 |
0.24 |
1.58 |
| Weighted Average Shares
Out |
$38.35 M
|
$38.66 M
|
$39.49 M
|
$38.74 M
|
$37.72 M
|
$37.89 M
|
$37.91 M
|
$37.91 M
|
$37.91 M
|
$6.00 M
|
| Weighted Average Shares
Out Diluted |
$40.38 M
|
$39.81 M
|
$40.68 M
|
$40.53 M
|
$39.75 M
|
$39.68 M
|
$37.97 M
|
$37.91 M
|
$37.91 M
|
$6.00 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
